Listed times are in Central European Time (CET)

WELCOME TO DAY ONE

Raymond Schiffelers UMC Utrecht, Netherlands

'Lipid nanoparticles to engineer CAR T cells in vivo'

Chair: Maria Caffarel

Q&A 12:25-12:35

Joaquin Arribas Hospital del Mar Research Institute, Spain

Q&A 12:55-13:05

Proffered Paper 1

Q&A 13:15-13:20

Proffered Paper 2

Q&A 13:30-13:35

INDUSTRY SPOTLIGHT - Lightcast Discovery

REFRESHMENT BREAK

Chair: Federica Sallusto

FLASH TALKS 1

Marleen Kok NKI, Netherlands

Q&A 14:30-14:40

Proffered Paper 3

Q&A 14:50-14:55

REFRESHMENT BREAK

FLASH TALKS 2

Proffered Paper 4

Q&A 15:30-15:35

Proffered Paper 5

Q&A 15:45-15:50

CLOSING KEYNOTE

Nathan West Genentech, USA

'Emerging cytokine-based strategies for cancer immunotherapy'

Q&A 16:15-16:30

SUMMARY AND CLOSE

Listed times are in Central European Time (CET)

WELCOME TO DAY TWO

Chair: Arianna Calcinotto

Pablo Menendez Josep Carreras Leukaemia Research Institute, Spain

'An armoured CAR-T cell strategy for Ewing sarcoma and osteosarcoma'

Q&A 12:25-12:35

EMBO Keynote Lecture

Eric Vivier Centre d’Immunologie de Marseille-Luminy, France

Q&A 12:55-13:05

Proffered Paper 6

Q&A 13:15-13:20

Proffered Paper 7

Q&A 13:30-13:35

REFRESHMENT BREAK

Chair: Antoni Celia

FLASH TALKS 3

Proffered Paper 8

Q&A 14:15-14:20

Alena Gros VHIO, Spain

Q&A 14:40-14:50

REFRESHMENT BREAK

FLASH TALKS 4

Arianna Calcinotto Institute of Oncology Research, Switzerland

'Neutrophils in cancer: heterogeneous and multifaceted'

Q&A 15:40-15:50

Proffered Paper 9

Q&A 16:00-16:05

DISCUSSION SESSION

Maria Caffarel, Nathan West, Joaquin Arribas

"How to translate the next generation immunotherapies to the clinic?"

CONFERENCE SUMMARY AND CLOSE